How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,141 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium (PubMed)

Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium Due to the specific physiology associated with pregnancy and puerperium, cerebral venous sinus thrombosis (CVT) may manifest different characteristics. This study aimed to identify the clinical manifestations and prognosis of pregnancy-associated CVT. A total of 43 pregnancy-associated CVT patients were enrolled. We analysed the clinical presentations of the disease (...) and performed a multivariate logistic regression analysis to determine which variables were associated with prognosis. Our descriptive results showed the following: 1) the incidence was 202 per 100,000 deliveries, and the mortality rate was 11.63%; 2) the most frequent symptom was headache; 3) the most frequent abnormal laboratory findings were increased levels of fibrinogen and several serum lipoproteins (including triglyceride, cholesterol, high-density lipoprotein, low-density lipoprotein, apolipoprotein

Full Text available with Trip Pro

2017 Scientific reports

142. Headache and migraine during pregnancy and puerperium: the MIGRA-study (PubMed)

Headache and migraine during pregnancy and puerperium: the MIGRA-study There is little prospectively gathered data on the course of headaches during pregnancy and postpartum, and the influence of breastfeeding is unclear. This is a large, prospective study, which invited all pregnant women in the catchment area during a defined period. All participants (n = 2,126) filled in questionnaires concerning headache. Among these, a total of 208 women with migraine according to the International (...) Headache Society criteria also filled in detailed headache diaries during pregnancy and the puerperal period. Freedom from earlier headaches during pregnancy was significantly more common than new onset of headache during pregnancy (p < 0.001). This was not influenced by prior use of oral contraceptives. According to the diaries, there was a gradual decrease during pregnancy in the frequency of all headaches and of self-considered migraine. There was also a significant decrease in the duration

Full Text available with Trip Pro

2011 The journal of headache and pain

143. Lead Screening During Pregnancy and Lactation

Lead Screening During Pregnancy and Lactation Lead Screening During Pregnancy and Lactation - ACOG Menu ▼ Lead Screening During Pregnancy and Lactation Page Navigation ▼ Number 533, August 2012 (Reaffirmed 2018) Committee on Obstetric Practice This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Lead Screening During (...) Pregnancy and Lactation Abstract: Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels. Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults. In 2010, the Centers for Disease Control and Prevention issued the first guidelines regarding the screening and management of pregnant and lactating women who have been exposed to lead

2012 American College of Obstetricians and Gynecologists

144. Brain metastases from breast cancer during pregnancy (PubMed)

Brain metastases from breast cancer during pregnancy Brain metastasis during pregnancy is a rare occurrence. In particular, there have only been three prior cases regarding breast cancer metastasis. We report a patient with breast cancer metastasis to the brain during pregnancy and review the literature.The patient was a 35-year-old female with a history of breast cancer (estrogen receptor/progesterone receptor negative, human epidermal growth factor receptor 2/neu positive, status post (...) -neoadjuvant docetaxel/carboplatin/trastuzumab/pertuzumab therapy, status post-bilateral mastectomies), and prior right frontal brain metastases (status post-resection, capecitabine/lapatinib/temozolomide therapy, and cyberknife treatment). Patient was found to be pregnant at 9 weeks' gestation while on chemotherapy; the patient elected to continue with the pregnancy and chemotherapy was discontinued. At 14 weeks' gestation, she returned with recurrent right frontal disease. She was taken for a craniotomy

Full Text available with Trip Pro

2016 Surgical neurology international

145. The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy

symptoms attributed to hypertension (headache, visual changes) prior to enrollment. Pulmonary edema. Elevated AST (>60 international units/L) or ALT (>70 international units/L) prior to enrollment. Low platelet count (<100,000/microliter) prior to enrollment. Renal insufficiency (creatinine > 1.1 or double the baseline creatinine if known) prior to enrollment. Chronic hypertension defined as hypertension pre-existing pregnancy or diagnosed prior to 20-weeks' gestation. Moderate- or severe-persistent (...) The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2016 Clinical Trials

146. NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes

(+/- 3) days ] % nutrient intake compare to estimated average requirements (EAR). Dietary intake: energy, protein, zinc, Fe Problems experience [ Time Frame: baseline, 30 (+/- 3), and 60 (+/- 3) days ] Number of problems(minor and serious) experience by the mother during pregnancy. Minor problems include: backache, constipation, cramp, feeling faint, hot, headache, etc. Serious problem: Slow-growing babies, Vaginal bleeding, Deep vein thrombosis, High blood pressure, pre-eclampsia, etc We (...) NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2016 Clinical Trials

147. Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. (PubMed)

Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes. This systematic review evaluates maternal tolerance and obstetric and perinatal outcomes following sildenafil citrate (SC) use in human pregnancy.Scopus, PubMed, Cochrane Library, Web of Science, Embase, and Google Scholar were searched. Relevant full-text studies including case series and reports in English were included. Publications were excluded if the pregnancy was terminated or if SC (...) was used only at conception.Sixteen studies were included (n = 165). Indications for use and outcomes were variably reported. Maternal outcomes reported were headache (45.8%, 49/107), visual disturbances (17.3%, 14/81), dyspepsia/epigastric pain (15.8%, 15/95), and hypotension (0%, 0/39). There were more caesarean (83.3%, 55/66) than vaginal deliveries (16.7%, 11/66) and postpartum haemorrhage occurred in 3.9% (3/76) of women exposed to SC. Neonatal outcomes including nursery admission (67.3%, 35/52

Full Text available with Trip Pro

2016 Fetal diagnosis and therapy

148. Spontaneous pituitary apoplexy during the second trimester of pregnancy, with sensory loss (PubMed)

Spontaneous pituitary apoplexy during the second trimester of pregnancy, with sensory loss A 32-year-old Hispanic woman at 23 weeks gestation presented with right-sided headache, associated with photophobia and right-sided numbness. She denied visual problems, menstrual irregularities and galactorrhoea. Examination revealed visual acuity 20/40 bilaterally with some blurriness on the left side, decreased right V1-V2 facial sensation and preserved 5/5 power, but decreased sensation over

Full Text available with Trip Pro

2016 BMJ case reports

149. Migraine Medications in Pregnancy

Medications in Pregnancy Migraine Medications in Pregnancy Aka: Migraine Medications in Pregnancy , Headache Medications in Pregnancy II. Management: Migraine Headache Abortive Medications See Sample protocol Mild to Moderate See ( ) Moderate to Severe Metoclopramide (Reglan) 10 mg orally or (not in first or third trimester) ( ) Consider (limit to 300 mg/day during pregnancy) Severe with (outpatient) or suppository PR Consider Consider (e.g. ) Severe with dehydration (admitted) replacement (...) obstetrics before use May be considered if s are uncontrolled, debilitating Adverse effects in pregnancy Avoid in first trimester (fetal malformations and adverse pregnancy outcomes) Risk of uterine atony and peripartum (but may be considered in debilitating ) III. Management: Migraine Headache Prophylactic Medications See Indications Intractable, frequent s and dehydration due to persistent s Most prophylactic agents are contraindicated Avoid s Avoid anticonvulsants (e.g. ) Prophylactic medications

2018 FP Notebook

150. A Clinical Study of Fundus Findings in Toxaemia of Pregnancy

A Clinical Study of Fundus Findings in Toxaemia of Pregnancy A Clinical Study of Fundus Findings in Toxaemia of Pregnancy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Clinical Study of Fundus Findings (...) in Toxaemia of Pregnancy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03076619 Recruitment Status : Completed First Posted : March 10, 2017 Last Update Posted : March 13, 2017 Sponsor: B. J. Medical College, Ahmedabad Collaborator: M and J Western Regional Institute of Ophthalmology,Ahmedabad

2016 Clinical Trials

151. Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016. (PubMed)

Miscarriage following dengue virus 3 infection in the first six weeks of pregnancy of a dengue virus-naive traveller returning from Bali to Italy, April 2016. We report miscarriage following dengue virus (DENV)-3 infection in a pregnant woman returning from Bali to Italy in April 2016. On her arrival, the woman had fever, rash, asthenia and headache. DENV RNA was detected in plasma and urine samples collected the following day. Six days after symptom onset, she had a miscarriage. DENV RNA

Full Text available with Trip Pro

2016 Euro Surveillance

152. Vertebral artery dissection in hypertensive disorders of pregnancy: a case series and literature review. (PubMed)

Vertebral artery dissection in hypertensive disorders of pregnancy: a case series and literature review. Arterial dissection is a rare complication of pregnancy and puerperium. There have been reports of aortic, coronary and cervical artery dissection in association with preeclampsia, however, vertebral artery dissection is rarely reported particularly in the antenatal setting in the presence of a Hypertensive Disorder of Pregnancy (HDP).The general annual incidence of symptomatic spontaneous (...) artery dissection in association with HDP, two of which occurred in the antenatal setting and two in the post-partum setting. All our patients had favourable outcome with no maternal neurological deficit and live infants. Our discussion covers the proposed pathophysiology of vertebral artery dissection in HDP and the management of it.Our case series highlights the need to consider VAD an important differential diagnosis when assessing pregnant women with headache and neck pain particularly

Full Text available with Trip Pro

2016 BMC Pregnancy and Childbirth

153. Abducens Nerve Palsy in Pregnancy: A Case Report (PubMed)

Abducens Nerve Palsy in Pregnancy: A Case Report Headache, blurring of vision and confusion are neurologic symptoms of preeclampsia. Whereas abducens nerve palsy during pregnancy is an extremely rare condition, we report here a 40-year-old patient with diplopia, blurring of vision and abducens nerve palsy in the 39th week of pregnancy with history of hypertension (HTN). No specific pathology was found. Symptoms of abducens nerve palsy were resolved spontaneously by controlling blood pressure

Full Text available with Trip Pro

2016 Journal of clinical and diagnostic research : JCDR

154. Health care seeking behaviours in pregnancy in rural Sindh, Pakistan: a qualitative study (PubMed)

. Qualitative analysis was done using NVivo version 10.Women stated they usually visited health facilities if they experienced pregnancy complications or danger signs, such as heavy bleeding or headache. Findings revealed the importance of husbands and mothers-in-law as decision makers regarding health care utilization. Participants expressed that poor availability of transport, financial constraints and the unavailability of chaperones were important barriers to seeking care. In addition, private (...) Health care seeking behaviours in pregnancy in rural Sindh, Pakistan: a qualitative study Pakistan has alarmingly high numbers of maternal mortality along with suboptimal care-seeking behaviour. It is essential to identify the barriers and facilitators that women and families encounter, when deciding to seek maternal care services. This study aimed to understand health-seeking patterns of pregnant women in rural Sindh, Pakistan.A qualitative study was undertaken in rural Sindh, Pakistan as part

Full Text available with Trip Pro

2016 Reproductive health

155. Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique (PubMed)

facility for the purpose of opening the antenatal record. Women without antenatal cards feared mistreatment during labour. Antenatal care was also sought to resolve discomforts, such as headaches, flu-like symptoms, body pain and backache. However, partners and husbands considered lower abdominal pain as the only symptom requiring care and discouraged women from revealing their pregnancy early in gestation. Health care providers for pregnant women often included those at the health facility, matrons (...) Barriers and facilitators to health care seeking behaviours in pregnancy in rural communities of southern Mozambique In countries, such as Mozambique, where maternal mortality remains high, the greatest contribution of mortality comes from the poor and vulnerable communities, who frequently reside in remote and rural areas with limited access to health care services. This study aimed to understand women's health care seeking practices during pregnancy, taking into account the underlying social

Full Text available with Trip Pro

2016 Reproductive health

156. Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache

Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache Sodium Oxybate in Patients With Episodic and Chronic Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Sodium Oxybate (...) in Patients With Episodic and Chronic Cluster Headache (SOinCH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02637648 Recruitment Status : Unknown Verified December 2015 by Ramin Khatami, Klinik Barmelweid. Recruitment status was: Not yet recruiting First Posted : December 22, 2015 Last Update Posted

2015 Clinical Trials

157. Pilot Study of DFN-11 Injection in Medication Overuse Headache

Pilot Study of DFN-11 Injection in Medication Overuse Headache Pilot Study of DFN-11 Injection in Medication Overuse Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pilot Study of DFN-11 Injection (...) in Medication Overuse Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02583425 Recruitment Status : Terminated First Posted : October 22, 2015 Results First Posted : April 3, 2018 Last Update Posted : April 3, 2018 Sponsor: Dr. Reddy's Laboratories Limited Information provided by (Responsible Party

2015 Clinical Trials

158. Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache Safety and Efficacy Study of SOM230 s.c. in Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy Study of SOM230 (...) s.c. in Cluster Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02619617 Recruitment Status : Terminated (Non-efficacy in first Phase 2a cohort.) First Posted : December 2, 2015 Last Update Posted : February 18, 2019 Sponsor: Novartis Pharmaceuticals Information provided by (Responsible

2015 Clinical Trials

159. Headache - assessment

, neck stiffness, weakness and visual disturbance. Contacts with similar symptoms. Consider possible carbon monoxide poisoning if household contacts or pets have similar symptoms. Precipitating and relieving factors such as: Trauma, posture, Valsalva manoeuvres, fatigue or stress, menstrual cycle, and medication change or withdrawal. Comorbidities and past medical history including: Compromised immunity, systemic illness, malignancy and pregnancy. Drug history including: Drugs used for headache (...) or immunosuppressive drugs) — consider serious causes such as cerebral infection or malignancy. Current or past malignancy — consider serious causes such as cerebral metastases. Current or recent pregnancy — consider serious causes such as pre-eclampsia. For further information, see the CKS topics on , , , and . Basis for recommendation Basis for recommendation The information on warning features that may indicate a serious secondary cause of headache is based on clinical guidelines Referral guidelines

2013 NICE Clinical Knowledge Summaries

160. Aminophylline for Patients With Post-Dural Puncture Headache

Aminophylline for Patients With Post-Dural Puncture Headache Aminophylline for Patients With Post-Dural Puncture Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Aminophylline for Patients With Post (...) -Dural Puncture Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02522013 Recruitment Status : Completed First Posted : August 13, 2015 Last Update Posted : October 31, 2016 Sponsor: The First Affiliated Hospital of Zhengzhou University Information provided by (Responsible Party): Chuanjie Wu

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>